11-101-2510
Letrozole Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Manufacturer: MilliporeSigma Supelco
CAS Number: 112809-51-5
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 11-101-2510-Each-of-1 | In Stock | ₹ 14,124.30 |
11-101-2510 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 14,124.30
GST (18%): ₹ 2,542.374
Total Price: ₹ 16,666.674
CAS
112809-51-5
Type
Certified Reference Material
Linear Formula
C17H11N5
Synonym
Letrozole; 4,4′-(1 H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile
Grade
Certified Reference Material
Quantity
1 g
Purity Grade Notes
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
MDL Number
MFCD00866241
Formula Weight
285.30
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Letrozole United States Pharmacopeia (USP) Reference Standard | 112809-51-5 | MFCD00866241 | 200MG | -- | ₹ 47,632.80 | ||
Letrozole | -- | ₹ 11,907.50 | ||
Letrozole | -- | ₹ 24,962.45 | ||
Letrozole | -- | ₹ 14,267.35 | ||
112809-51-5 | 4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile | -- | ₹ 3,560.00 - ₹ 95,586.00 |
Related Products
Description
- Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Letrozole is used for the treatment of breast cancer in hormone-dependent postmenopausal patients
- The drug works by blocking the synthesis of estrogen, a causative agent for cancer.